{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:35:05Z","timestamp":1793316905679,"version":"4.5.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Idiopathic inflammatory myopathies (IIMs) are rare systemic diseases associated with significant morbidity and mortality. The aim of our study was to estimate for the first time the survival of IIM patients in Slovenia.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We included IIM patients diagnosed between January 2005 and December 2020 and followed at two secondary\/tertiary rheumatology centers in the country. To study survival\/mortality the censor date of April 14 2021 was set. Kaplan\u2013Meier analysis and standardized mortality ratio (SMR) were plotted using data of age and sex matched Slovenian population as a reference. Cox proportional hazards regression analysis was used to study prognostic factors for IIM mortality.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> During the 16-year observation period, we identified 217 new IIM patients. During follow up 65 (30.0%) patients died. In the first year following IIM diagnosis the SMR was nearly 7-fold higher compared to the matched general population [SMR 6.88 (95%CI 4.41\u201310.24)] and remained higher also during the following 4 years. However, when excluding IIM patients with cancer, the survival outcome was, except in the first year after IIM diagnosis [SMR 5.55 (95%CI 3.10\u20139.15)], comparable to matched general population. In addition to cancer [HR 3.71 (95% CI 2.18\u20136.04)], cardiac involvement [HR 2.18 (95% CI 1.07\u20134.45)], fever [HR 2.13 (95% CI 1.13\u20134.03)], and older age [HR 1.07 (95% CI 1.04\u20131.09)] were extracted as prognostic factors associated with death.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The survival of patients with IIM patients was substantially worse compared to matched general population. Cancer was the leading cause of death in our cohort.<\/jats:p>","DOI":"10.3389\/fmed.2021.801078","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T17:48:50Z","timestamp":1640022530000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Survival of Patients With Idiopathic Inflammatory Myopathies in Slovenia"],"prefix":"10.3389","volume":"8","author":[{"given":"Alojzija","family":"Ho\u010devar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Vir\u0161\u010dek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kro\u0161el","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzana","family":"Gradi\u0161nik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017diga","family":"Rotar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matija","family":"Tom\u0161i\u010d","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iztok","family":"Holc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"9","author":"Selva-O'Callaghan","year":"2018","journal-title":"Lancet Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780140210","article-title":"Factors affecting survivorship in polymyositis. A life-table study of 124 patients","volume":"2","author":"Medsger","year":"1971","journal-title":"Arthritis Rheum."},{"key":"B3","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/art.1780280303","article-title":"Prognostic factors in polymyositis\/dermatomyositis. A computer-assisted analysis of ninety-two cases","volume":"3","author":"Benbassat","year":"1985","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/08916930600622603","article-title":"Survival, mortality and causes of death in inflammatory myopathies","volume":"3","author":"Torres","year":"2006","journal-title":"Autoimmunity."},{"key":"B5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases","volume":"1","author":"Dank\u00f3","year":"2004","journal-title":"Medicine (Baltimore)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1007\/s00296-017-3799-x","article-title":"Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain","volume":"11","author":"Nu\u00f1o-Nu\u00f1o","year":"2017","journal-title":"Rheumatol Int."},{"key":"B7","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00408-016-9896-x","article-title":"Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease","volume":"5","author":"Johnson","year":"2016","journal-title":"Lung."},{"key":"B8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/annrheumdis-2017-211402","article-title":"Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study","volume":"1","author":"Dobloug","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"5","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul Disord."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1093\/brain\/aww054","article-title":"High risk of cancer in autoimmune necrotizing myopathies: usefulness of myositis specific antibody","volume":"8","author":"Allenbach","year":"2016","journal-title":"Brain."},{"key":"B11","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"7","author":"Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-212786","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"12","author":"Lundberg","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","article-title":"Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years Chest","volume":"6","author":"Connors","year":"2010"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/jnci\/djg052","article-title":"Comparing survival of a sample to that of a standard population","volume":"19","author":"Finkelstein","year":"2003","journal-title":"J Natl Cancer Inst."},{"key":"B15","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12874-017-0351-3","article-title":"On comparison of net survival curves","volume":"1","author":"Pavli\u010d","year":"2017","journal-title":"BMC Med Res Methodol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1093\/rheumatology\/41.1.22","article-title":"Outcome in patients with idiopathic inflammatory myositis: morbidity and mortality","volume":"1","author":"Sultan","year":"2002","journal-title":"Rheumatology (Oxford)."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s10067-019-04910-w","article-title":"Mortality of Chinese patients with polymyositis and dermatomyositis","volume":"5","author":"Yang","year":"2020","journal-title":"Clin Rheumatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1007\/s10067-016-3296-8","article-title":"Malignancy in dermatomyositis and polymyositis: analysis of 192 patients","volume":"8","author":"Fang","year":"2016","journal-title":"Clin Rheumatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/1756-185X.14128","article-title":"Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy","volume":"24","author":"Bai","year":"2021","journal-title":"Int J Rheum Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1093\/rheumatology\/keab001","article-title":"High early mortality in idiopathic inflammatory myopathies: results from the inception cohort at a tertiary care centre in northern India","volume":"60","author":"Mehta","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1136\/annrheumdis-2017-211868","article-title":"The EuroMyositis registry: an international collaborative tool to facilitate myositis research","volume":"1","author":"Lilleker","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"keab573","DOI":"10.1093\/rheumatology\/keab573","article-title":"Defining cardiac involvement in idiopathic inflammatory myopathies: a systematic review","volume":"17","author":"Fairley","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1002\/clc.22026","article-title":"Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review","volume":"11","author":"Zhang","year":"2012","journal-title":"Clin Cardiol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.autrev.2014.01.022","article-title":"Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review","author":"Mahler","year":"2014","journal-title":"Autoimmun Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s10067-005-1164-z","article-title":"Prognosis and mortality of polymyositis and dermatomyositis patients","volume":"2","author":"Airio","year":"2006","journal-title":"Clin Rheumatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1136\/annrheumdis-2017-211400","article-title":"2016 American College of Rheumatology\/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group\/Paediatric Rheumatology International Trials Organisation Collaborative Initiative","volume":"76","author":"Aggarwal","year":"2017","journal-title":"Ann Rheum Dis."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.801078\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T17:48:53Z","timestamp":1640022533000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.801078\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":26,"alternative-id":["10.3389\/fmed.2021.801078"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.801078","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"article-number":"801078"}}